Not enough data
Fred Pennic's coverage primarily focuses on the healthcare and pharmaceutical industry. His articles heavily feature press releases and private sector announcements, indicating a preference for news directly from companies in the industry.
To effectively reach Fred, consider providing exclusive details or insights into mergers and acquisitions within the healthcare sector, advancements in AI technology in healthcare, Medicare-related developments, or innovations in healthcare technology. As his focus does not seem to be confined to a specific geographic area, pitches should aim to provide valuable information relevant to global audiences within the healthcare and pharmaceutical space.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Fred Pennic
Consumer health platform Function Health secured $450M in non-dilutive growth financing from General Catalyst’s Customer Value Fund (CVF). The mega-round comes just eight months after Function’s $298M Series B, accelerating its goal of scaling direct-to-consumer lab testing, full-body imaging, and personalized AI analytics.
NYU Langone Health and Dana-Farber Cancer Institute have co-developed the Solavia Decision Suite, an oncology decision support platform designed to deliver precise, evidence-based, and standardized care delivery at scale. Solavia launched internally at NYU Langone on June 30, 2026, and is now commercially available to external health systems and oncology centers.
By: Fred Pennic
Amae Health announced a strategic collaboration with Google Health Enterprise to integrate continuous, wearable-derived behavioral metrics into its precision psychiatry model. The collaboration feeds wearable data from Google Health apps and Fitbit devices directly into Amae’s multidisciplinary care team workflows to track physiological and behavioral markers.
By: Fred Pennic
Healthcare data and AI platform H1 announced a strategic partnership with global pharmaceutical leader Novo Nordisk to modernize clinical trial development. Under the agreement, H1 will acquire rights to further advance StudyHub, Novo Nordisk’s proprietary digital and AI-enabled platform for clinical trial execution.
By: Fred Pennic
Tel Aviv-based AI clinical simulation platform QuantHealth closed a $45 million Series B financing round led by Qumra Capital. The round saw participation from major strategic and venture investors, including Sanofi Ventures, Pitango HealthTech, Bertelsmann Healthcare Investments (BHI), Artofin, GC Ventures, NewHealth, Shoni Top, and Esplanade Ventures.
New Haven-based cardiopulmonary digital health provider Wellinks closed a $10M first tranche of its Series B funding round. The financing was led by strategic partner UMass Memorial Health alongside participation from existing inside investors.
By: Fred Pennic
Global healthcare IT consulting firm Nordic® announced the opening of a new delivery facility in Mexico to expand its nearshore technical capabilities. The Mexico facility will support core digital transformation domains, including Epic services, application managed services (AMS), cloud infrastructure, data and analytics, and emerging AI-enabled health system solutions.
By: Fred Pennic
Independent accreditor URAC announced that Guidehealth, RediMinds, and SandsRx are the first three organizations nationwide to earn its Health Care Artificial Intelligence Accreditation. Launched in 2025, URAC’s AI accreditation framework evaluates organizations across the entire technology lifecycle, focusing on governance, risk management, transparency, and ongoing operational oversight.
By: Fred Pennic
Digital health provider Hinge Health, Inc. announced a definitive agreement to acquire virtual-first digestive care company Cylinder Health, Inc. for $105M in cash. The transaction is expected to close in the third quarter of 2026, subject to customary closing conditions.
By: Fred Pennic
What You Should Know New Haven-based cardiopulmonary digital health provider Wellinks closed a $10M first tranche of its Series B funding round.
